- NuScale Power and MillenniTEK recently fabricated first-of-a-kind boron-oxide pellets for NuScale’s passive emergency core cooling system, a safety-critical component of its U.S. Nuclear Regulatory Commission–approved small modular reactor design.
- Coupled with NuScale’s deployment of nuclear-specific AI tools from Nuclearn and NPX to streamline engineering and regulatory work, these advances highlight how the company is building out both the hardware and knowledge infrastructure needed for eventual commercial deployment.
- We’ll now examine how this progress on safety-critical component fabrication shapes NuScale’s existing investment narrative around commercialization and project execution.
AI is about to change healthcare. These 37 stocks are working on everything from early diagnostics to drug discovery. The best part – they are all under $10b in market cap – there’s still time to get in early.
NuScale Power Investment Narrative Recap
To own NuScale, you have to believe that its NRC approved small modular reactor design can convert engineering milestones into binding power purchase agreements, especially with TVA and RoPower in Romania, before cash burn and dilution bite too hard. The new boron oxide pellet achievement strengthens NuScale’s technical readiness, but it does not directly change the near term dependence on signing PPAs or the risk that commercialization timelines slip.
The AI collaboration with Nuclearn and NPX is particularly relevant here, because it aims to speed up how NuScale handles engineering, licensing evidence, and standards as projects move toward deployment. Faster, more traceable information retrieval could support smoother NRC interactions and customer project development, which in turn ties back to the same core catalysts investors are watching most closely firm PPAs and successful execution on early reference plants.
Yet behind the promise of first of a kind safety components, investors should also be aware of the risk that prolonged commercialization timelines and cash burn could…
Read the full narrative on NuScale Power (it’s free!)
NuScale Power’s narrative projects $442.0 million revenue and $49.7 million earnings by 2029. This requires 245.8% yearly revenue growth and a $465.4 million earnings increase from -$415.7 million today.
Uncover how NuScale Power’s forecasts yield a $12.63 fair value, a 30% upside to its current price.
Exploring Other Perspectives
While recent safety and AI milestones point to progress, the most cautious analysts still expected only about US$134.0 million of revenue and US$15.0 million of earnings by 2029, highlighting how much more skeptical they are about NuScale’s ability to turn frameworks into firm PPAs and profitable projects compared with the baseline view, and why your own outlook might shift as new developments come through.
Explore 11 other fair value estimates on NuScale Power – why the stock might be worth less than half the current price!
The Verdict Is Yours
Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.
- A great starting point for your NuScale Power research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
- Our free NuScale Power research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate NuScale Power’s overall financial health at a glance.
No Opportunity In NuScale Power?
Opportunities like this don’t last. These are today’s most promising picks. Check them out now:
- The latest GPUs need a type of rare earth metal called Neodymium and there are only 30 companies in the world exploring or producing it. Find the list for free.
- We’ve uncovered the 11 dividend fortresses yielding 5%+ that don’t just survive market storms, but thrive in them.
- Explore 25 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
This article by Simply Wall St is general in nature. We provide commentary based on historical data
and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your
financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.
Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we’re here to simplify it.
Discover if NuScale Power might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Have feedback on this article? Concerned about the content? Get in touch with us directly.Alternatively, email editorial-team@simplywallst.com
You can copy Bill Ackman and buy Netflix. Knowing why you did is the hard part.
Netflix case is interesting. The scariest competitor is the one that does not need to make money. Amazon can run video at a loss forever because it is really a Prime retention tool with a content budget attached. On the other hand there is Youtube.
Pershing Square hasn’t beaten the S&P over the last five years, though the long-run record is genuinely good. I like Ackman as a person. I enjoy listening to Ackman and that’s about where it ends for me.
Mitchell Lawler
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picks
Fresh 13F filings are where some investors go to find their next stock pick. The problem is it’s missing some of the most important details for making a good investment.
10
Sep 4, 2026
About NYSE:SMR
NuScale Power
Provides small modular reactor technology solutions.
Flawless balance sheet with low risk.
Similar Companies
Market Insights
What 13F filings won’t tell you about a billionaire’s stock picksMI
Mitchell Lawler
Great earnings season, but are the earnings real?AN
Andrew Legget
Which payment stocks actually get paid?MI
Mitchell Lawler
Advertisement
Weekly Picks
Lou_Baseneseon Oncolytics Biotech·17 days ago
The Team Behind a $2 Billion Johnson & Johnson (JNJ) Deal Just Took Over This $105 Million Cancer Biotech
Fair Value:US$3.575.9% undervalued
61followersusers have followed this narrative
·1commentusers have commented on this narrative
·15likesusers have liked this narrative
AN
andrei9868on ServiceNow·21 days ago
The Platform Turning Enterprise Chaos into Autonomous Workflows
John_Ericon Vistra·5 days ago
Vistra Fell 38%. Adjusted EBITDA Rose 31%. Here’s the $472 Million Reason They Disagree.
HarishPKon EverQuote·15 days ago
EverQuote and an Asymmetric Investment Opportunity
RecentlyUpdated Narratives
QuanDon Shopify·44 minutes ago
The Default Platform for Entrepreneurs that Keeps Compounding
John_Ericon Hamilton Lane·about 5 hours ago
Analysts Cut Their Targets. The Co-Chairman Cut a Check.
LunaRodason KNOT Offshore Partners·about 7 hours ago
KNOP | KNOT Offshore Partners LP: What They Said vs. What They Did
Popular Narratives
oscargarciaon NVIDIA·3 months ago
The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.
John_Ericon MercadoLibre·about 8 hours ago
MercadoLibre and the Spreadsheet Trick That Decides Everything
Fair Value:US$3.68k46.2% undervalued
129followersusers have followed this narrative
·3commentsusers have commented on this narrative
·18likesusers have liked this narrative
ANAnalystConsensusTargeton NVIDIA·about 1 month ago
